Clinical Trial Update: Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome [Phase 2]

View source ↗

Summary

Clinical trial evaluating mogamulizumab with low-dose total skin electron beam therapy in Sézary syndrome and mycosis fungoides, Phase 2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Mogamulizumab (mogamulizumab)

Snippet

Sponsor: Stanford University | Conditions: Sezary Syndrome, Mycosis Fungoides | Phase 2 | Status: RECRUITING